StrokeNet Thrombectomy Endovascular Platform - Trial NCT06289985
Access comprehensive clinical trial information for NCT06289985 through Pure Global AI's free database. This phase not specified trial is sponsored by Medical University of South Carolina and is currently Not yet recruiting. The study focuses on Ischemic Stroke. Target enrollment is 2000 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Endovascular thrombectomy with any FDA-approved category POL or NRY device
Interventional
device
Sponsor & Location
Medical University of South Carolina
Timeline & Enrollment
N/A
Jun 01, 2024
Sep 01, 2028
Primary Outcome
Global disability measured by Modified Rankin Score
Summary
STEP is a Randomized, Multifactorial, Adaptive Platform trial that seeks to optimize the care
 of patients with acute ischemic stroke (AIS) due to large (LVO) or medium vessel occlusions
 (MVO).
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06289985
Device Trial